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Abstract: Solid tumor development requires angiogenesis and is correlated to the expression of 
inflammatory markers through cellular metabolic and energetic adaptation. While high glycolysis 
rates enable the cancer cell compartment to generate adenosine triphosphate (ATP), very little is 
known about the impact of low intracellular ATP concentrations within the vascular endothelial 
cell compartment, which is responsible for tumor angiogenesis. Here, we investigated the effect 
of 2-deoxy-D-glucose (2-DG), a glucose analog that inhibits glycolysis through intracellular 
ATP depletion, on human brain microvascular endothelial cell (HBMEC) angiogenic properties. 
While preformed capillaries remained unaffected, we found that in vitro tubulogenesis was 
dose-dependently decreased by 2-DG and that this correlated with reduced intracellular ATP 
levels. Procarcinogenic signaling was induced with phorbol 12-myristate 13-acetate (PMA) 
and found to trigger the proinflammatory marker cyclooxygenase-2 (COX-2) and endoplasmic 
reticulum (ER) stress marker GRP78 expression, whose inductions were potentiated when 
PMA was combined with 2-DG treatment. Inversely, PMA-induced matrix-metalloproteinase-9 
(MMP-9) gene expression and protein secretion were abrogated in the presence of 2-DG, and 
this can be partially explained by reduced nuclear factor-κB signaling. Collectively, we provide 
evidence for an intracellular ATP requirement in order for tubulogenesis to occur, and we link 
increases in ER stress to inflammation. A better understanding of the metabolic adaptations of 
the vascular endothelial cells that mediate tumor vascularization will help the development of 
new drugs and therapies.
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Introduction
Tumor-associated angiogenesis, a fundamental process in tumor growth and metastasis, 
consists of recruiting endothelial cells (EC) toward an angiogenic stimulus.1 The cells 
subsequently proliferate and differentiate to form endothelial tubes and capillary-like 
structures in order to deliver nutrients and oxygen to the tumor and to remove the 
products of its metabolism. In recent years several pathways have, in addition to 
stimulation of tumor angiogenesis, been suggested to contribute to the cell metabolic 
adaptations required for carcinogenesis, which include decreased tumoral apoptosis, 
increased invasion and metastasis, immune suppression, and tumor-associated 
inflammation.2,3
An interesting link between overexpression of the pro-inflammatory marker 
cyclooxygenase-2 (COX-2) and tumor angiogenesis was recently described as one Journal of Inflammation Research 2011:4 submit your manuscript | www.dovepress.com
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such metabolic adaptative phenotype.4–6 This is supported 
by the fact that in normal cerebral cortex COX-2 is only 
present in neurons but absent from vascular EC.7,8 It is 
however still unknown whether the EC-associated COX-2 
correlates with high malignancy. Furthermore, little is 
known about the molecular events that dictate metabolic 
adaptation of EC in response to procarcinogenic stimuli. 
It is tempting to suggest that specific inhibition of metabolic 
pathways may offer a novel therapeutic approach that would 
simultaneously inhibit tumor-induced angiogenesis and 
inflammatory phenotypes.9,10
While human brain microvascular endothelial cells 
(HBMEC) play an essential role as structural and functional 
components of the blood–brain barrier (BBB), its disruption 
by the brain tumor-secreted matrix metalloproteinase-9 
(MMP-9) is believed to favor tumor invasion.11,12 Recent 
studies delineated a unique brain endothelial pheno-
type in which MMP-9 secretion by HBMEC was incr-
eased upon treatment with the tumor-promoting agent 
phorbol 12-myristate 13-acetate (PMA).13,14 Inhibition 
of MMP-9 secretion was demonstrated to reduce both in 
vitro invasion and angiogenesis in human microvascular 
EC.15 In fact, adenoviral-mediated MMP-9 downregula-
tion inhibited human dermal microvascular EC migration 
in cell wounding and spheroid migration assays, and 
reduced capillary-like tube formation, demonstrating 
the key role of MMP-9 in EC network organization.15 
Therefore, among all MMP, the MMP-9 secreted from 
brain EC may be of importance in brain tumor-associated 
neovascularization.
Among the numerous signaling pathway candidates, 
nuclear factor-κB (NF-κB) can regulate the expression of 
COX-2 through endoplasmic reticulum (ER) stress and, in 
part, through induction of the ER chaperone GRP78/BiP, 
which is expressed at high levels in a variety of tumors 
and which confers drug resistance to both proliferating 
and dormant cancer cells.16 Importantly, it was recently 
demonstrated that partial reduction of GRP78 substantially 
reduced tumor microvessel density.17 In the current study, 
we treated HBMEC with 2-deoxy-D-glucose (2-DG) which, 
once phosphorylated by hexokinase to 2-deoxyglucose-
6-phosphate, cannot be further metabolized and leads to 
a blockade of glycolysis and to depletion of intracellular 
adenosine triphosphate (ATP). In vitro tubulogenesis, 
expression of ER stress marker GRP78, PMA-induced 
MMP-9 secretion, and COX-2 were also assessed in order to 
provide a metabolic and adaptative link between endothelial 
inflammation and angiogenesis.
Materials and methods
Materials
2-Deoxy-D-glucose, sodium dodecylsulfate (SDS) and 
bovine serum albumin (BSA) were purchased from Sigma-
Aldrich Canada (Oakville, Canada). Electrophoresis reagents 
were purchased from Bio-Rad (Mississauga, Canada). The 
enhanced chemiluminescence (ECL) reagents were from 
Perkin Elmer (Waltham, MA). Micro bicinchoninic acid 
protein assay reagents were from Pierce (Rockford, IL). 
The polyclonal antibodies against IκB and phospho-IκB 
were purchased from Cell Signaling (Danvers, MA). The 
monoclonal antibodies against GRP78 and GAPDH were 
from Advanced Immunochemical Inc (Long Beach, CA). 
Horseradish peroxidase-conjugated donkey anti-rabbit and 
anti-mouse IgG secondary antibodies were from Jackson 
ImmunoResearch Laboratories (West Grove, PA). All other 
reagents were from Sigma-Aldrich Canada.
cell culture
HBMEC were characterized and generously provided by 
Dr. Kwang Sik Kim of the Johns Hopkins University School 
of Medicine (Baltimore, MD). These cells were positive for 
factor VIII-Rag, carbonic anhydrase IV , and Ulex Europeus 
Agglutinin I; they took up fluorescently labeled, acetylated 
low-density lipoprotein and expressed gamma glutamyl trans-
peptidase, demonstrating their brain EC-specific phenotype.18 
HBMEC were immortalized by transfection with simian virus 
40 large T antigen and maintained their   morphological and 
functional characteristics for at least 30 passages.19 HBMEC 
were maintained in RPMI 1640 (Gibco, Burlington, Canada) 
supplemented with 10% (v/v) heat-inactivated fetal bovine 
serum (iFBS) (HyClone Laboratories, Logan, UT), 10% 
(v/v) NuSerum (BD Bioscience, Mountain View, CA), 
modified Eagle’s medium nonessential amino acids (1%) 
and vitamins (1%) (Gibco), sodium pyruvate (1 mM) and 
EC growth supplement (30 µg/mL). Culture flasks were 
coated with 0.2% type-I collagen to support the growth of 
HBMEC monolayers. Cells were cultured at 37°C under a 
humidified atmosphere containing 5% CO2. All experiments 
were performed using passages 3 to 28.
endothelial cell morphogenesis assay
Tubulogenesis was assessed using Matrigel aliquots of 
50 µL, plated into individual wells of 96-well tissue culture 
plates (Costar, Amherst, MA) and allowed to polymerize at 
37°C for 30 min. After brief trypsinization, HBMEC were 
washed and resuspended at a concentration of 106 cells/mL 
in serum-free medium. Twenty-five microliters of cell Journal of Inflammation Research 2011:4 submit your manuscript | www.dovepress.com
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suspension (25,000 cells/well) and 75 µL of medium 
with serum were added into each culture well. Cells were 
allowed to form capillary-like tubes at 37°C in 5% CO2/95% 
air for 20 h in the presence or absence of different 2-DG 
concentrations. The formation of capillary-like structures 
was examined microscopically and images (100×) were 
recorded using a Retiga 1300 camera (QImaging, Surrey, 
Canada) and an Eclipse TE2000-U microscope (Nikon, 
Melville, NY). The extent to which capillary-like structures 
formed in the gel was quantified by analysis of digitized 
images to determine the thread length of the capillary-like 
network, using a commercially available image analysis 
program (Northern Eclipse; Empix, Mississauga, Canada) as 
described and validated previously.20,21 For each experiment, 
four randomly chosen areas were quantified by counting the 
number of tubes formed. Tubulogenesis data are expressed 
as a mean value derived from at least three independent 
experiments.
gelatin zymography
Gelatin zymography was used to assess the extent 
of proMMP-2 and proMMP-9 activity as described 
previously.22 Briefly, an aliquot (20 µL) of the culture 
medium was subjected to SDS-PAGE in a gel containing 
0.1 mg/mL gelatin. The gels were then incubated in 2.5% 
Triton X-100 and rinsed in nanopure distilled H2O. Gels 
were further incubated at 37°C for 20 h in 20 mM NaCl, 
5 mM CaCl2, 0.02% Brij-35, 50 mM Tris-HCl buffer, pH 
7.6, then stained with 0.1% Coomassie Brilliant blue R-250 
and destained in 10% acetic acid, 30% methanol in H2O. 
Gelatinolytic activity was detected as unstained bands on a 
blue background.
Immunoblotting procedures
Proteins or nuclear extracts were isolated from   control 
and  treated  cells  using  the  NE-PER  Nuclear  and 
  cytoplasmic extraction kit (Pierce) and were separated by 
SDS–  polyacrylamide gel electrophoresis (PAGE). After elec-
trophoresis, proteins were electrotransfered to polyvinylidene 
difluoride membranes which were then blocked for 1 h at 
room temperature with 5% nonfat dry milk in Tris-buffered 
saline (150 mM NaCl, 20 mM Tris–HCl, pH 7.5) containing 
0.3% Tween-20 (TBST). Membranes were further washed 
in TBST and incubated with the primary antibodies (1/1000 
dilution) in TBST containing 3% bovine serum albumin, 
followed by a 1 h incubation with horseradish peroxidase-
conjugated anti-rabbit or anti-mouse IgG (1/2,500 dilution) 
in TBST containing 5% nonfat dry milk. Immunoreactive 
material was visualized by enhanced chemiluminescence 
(Amersham Biosciences, Baie d’Urfée, Canada).
analysis of cell death by flow cytometry
Cell death was assessed by flow cytometry as described 
previously.23 Adherent and floating cells were harvested 
by trypsin digestion and gathered to produce a single 
cell suspension. The cells were pelleted by centrifugation 
and washed with phosphate-buffered saline (PBS). Then, 
105 cells were pelleted, resuspended in 200 µL of buffer 
solution, and stained with annexin-V-fluorescein isothio-
cyanate and propidium iodide (PI) according to the manu-
facturer’s protocol (BD Biosciences, Mississauga, Canada). 
The cells were diluted by adding 300 µL of buffer solution 
and processed for data acquisition and analysis on a Becton 
Dickinson FACS Calibur flow cytometer using CellQuest 
Pro software.
analysis of autophagy by fluorescent 
microscopy and flow cytometry
HBMEC were seeded onto 12-well plates and cultured for 18 
h to reach 80% confluence. Cells were then exposed to dif-
ferent concentrations of 2-DG in the presence or absence of 
PMA (1 µM) in serum-free medium at 37°C in 5% CO2/95% 
air. Acridine orange was added to the culture medium at a final 
concentration of 0.5 µg/mL and incubated for 15 min in the dark 
at 37°C. The cells were then washed two times with medium 
lacking phenol red. Cells were immediately analyzed by flow 
cytometry or images taken with a fluorescent microscope using 
510–560 nm for excitation and 590 nm for emission.
Intracellular ATP levels assay
Cells were treated and 10X–100X-diluted lysates kept on 
ice as described by the manufacturer (Sigma). One hundred 
microliters of ATP mix was added to the lysates and incu-
bated at room temperature for 3 min. Somatic cell ATP-
releasing reagent (1X) was prepared and added to the cell 
lysates. From this solution 100 µL was added to the ATP 
mix prior to analysis by spectrofluorimetry.
statistical analysis
Statistical analyses were performed with Student’s t-test 
when one group was compared with the control group. To 
compare two or more groups with the control group, one-way 
analysis of variance (ANOVA) with Dunnett’s post hoc 
test was used. All statistical analyses were performed using 
Prism software (GraphPad, La Jolla, CA). Differences with 
P , 0.05 were considered significant.Journal of Inflammation Research 2011:4
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Figure 1 2-Dg (mM) depletes intracellular aTP and inhibits in vitro capillary-like structure formation in hBMec. In order to assess the impact of aTP requirement for in vitro 
tubulogenesis, hBMec were seeded on top of Matrigel as described in the Methods section and left to form structures. A) capillaries were then treated with 2-Dg (mM) or 
Mannose (mM). B) The impact of 2-Dg was also monitored during the formation of the structures, where cells were treated with various concentrations of 2-Dg 30 min after 
seeding of the cells on top of Matrigel, and structure formation monitored after 18 h. Representative phase contrast pictures were taken. C) The extent of three-dimensional 
capillary-like structure formation (tubulogenesis) and of cell survival was assessed as described in the Methods section. D) Intracellular aTP as well as total protein content 
were assessed as described in the Methods section in vehicle- or 2-Dg-treated cells. The length of the tube network was quantitated using northern eclipse software.
Notes: Values are means of two independent experiments (*P , 0.01 versus control alone); bars, ± sD.
Abbreviations: hBMec human brain microvasular endothelial cell; aTP, adenosine triphosphate; 2-Dg, 2 deopy-D-glucose.
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Results
2-Deoxy-D-glucose depletes intracellular 
ATP and inhibits in vitro capillary-like 
structure formation in hBMec
We first tested the effects of 2-DG against the angiogenic 
properties of HBMEC. Cells were seeded on top of Matrigel 
and left to adhere as described in the Methods section. Upon 
capillary-like structure formation, we then added 10–100 mM 
2-DG or Mannose. No effect was found on the integrity of 
the preformed structures (Figure 1A). In contrast, when 
various concentrations of 2-DG were added at the very early 
time points (ie, 30 min after cell seeding on top of Matrigel), 
cell structure formation was significantly decreased with 
a half maximal inhibitory concentration (IC50) of 4.1 mM 
(Figure 1B). Cell survival was assessed with annex-
in-V-fluorescein isothiocyanate (apoptosis) and propidium 
iodide (necrosis) and was not significantly affected by 2-DG 
(Figure 1C). Mannose did not affect the capacity of the cells 
to form structures (not shown). We also validated 2-DG’s 
ability to deplete intracellular ATP levels in HBMEC. While 
vehicle or 2-DG treatment did not affect total protein content 
levels (Figure 1D), we found that intracellular ATP levels 
decreased by ∼20% in vehicle-treated cells during the 24 
h incubation prior to which tube formation was assessed 
(Figure 1D, left panel). When cells were treated with 100 mM 
2-DG, .60% of intracellular ATP was depleted within the 
first hour of treatment, and .90% depletion was achieved 
at 4 h of treatment (Figure 1D, right panel). ATP-dependent 
inhibition of tubulogenesis was investigated next to find out 
whether any extracellular matrix (ECM) degrading events 
were involved in this 2-DG effect.
2-Deoxy-D-glucose inhibits PMA-induced 
MMP-9 secretion in hBMec
Among the secreted enzymes involved in ECM deg-
radation, matrix metalloproteinases (MMP) are well Journal of Inflammation Research 2011:4
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Figure 2 2-Dg inhibits PMa-induced MMP-9 secretion in hBMec. hBMec were 
serum-starved in the presence of various concentrations of 2-Dg in combination 
with vehicle or 1 µM PMa for 18 h. A) conditioned media were then harvested and 
gelatin zymography was performed in order to detect proMMP-9 and proMMP-2 
hydrolytic activity as described in the Methods section. B) scanning densitometry was 
used to quantify the extent of either basal proMMP-2 gelatin hydrolysis (open circles), 
or proMMP-9 (closed circles) in PMa-treated cells.
Note: Data shown are representative of two independent experiments.
Abbreviations:  2-Dg,  2-dexy-D-glucose;  hBMec,  mitovasuila  endothelial  cells; 
MMP,  matrix  metalloproteinase;  PMa,  phorbol  12-myristate  13-acetate;  gaDPh, 
glyceraldetyde 3- phisiphate dehydrogenase; Page, pohyacrylanide electrophoresis.
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Figure  3  2-Dg  inhibits  PMa-induced  IκB  phosphorylation  that  leads  to  IκB 
degradation. A) hBMec were serum-starved for 30 min in the presence of either 
vehicle or 100 mM 2-Dg. cells were then incubated for the indicated time with 1 µM 
PMa. lysates were isolated, electrophoresed via sDs-Page and immunodetection 
of phosphorylated IκB (P-IκB), IκB, and of gaPDh proteins was performed as 
described in the Methods section. B) Quantification was performed by scanning 
densitometry of the autoradiograms. Data were expressed as x-fold induction over 
basal untreated cells of the P-IκB/IκB ratios in vehicle pre-treated cells (open circles) 
and 2-Dg pre-treated cells (closed circles).
Abbreviations:  2-Dg,  2-dexy-D-glucose;  hBMec,  mitovasuila  endothelial  cells; 
MMP,  matrix  metalloproteinase;  PMa,  phorbol  12-myristate  13-acetate;  gaDPh, 
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documented as being involved in cell migration and 
tubulogenesis.13,24 More specifically, MMP-2 and MMP-9 
are secreted by numerous cell types and their presence is 
often representative of angiogenesis.25,26 HBMEC were 
serum-starved, treated for 18 h with 2-DG, and the con-
ditioned media were harvested to measure the levels of 
MMP-2 and of MMP-9 in both control and in PMA-treated 
cells by gelatin zymography. While MMP-2 extracellular 
levels were unaffected by 2-DG or by PMA (Figure 2A), 
MMP-9 levels were undetectable in basal conditions 
but were significantly increased in PMA-treated cells 
(Figure 2A, lower panel); the simultaneous presence of 
2-DG significantly attenuated the MMP-9 levels seen in 
the presence of PMA with an IC50 of ∼18.1 mM (Fig-
ure 2B). Collectively, these results suggest that changes 
in intracellular ATP levels do not inhibit MMP vesicular 
trafficking since MMP-2 secretion was unaffected, but do 
affect signal transducing events such as those triggered by 
PMA and which control MMP-9 secretion.
2-Deoxy-D-glucose inhibits  
PMA-induced IκB phosphorylation  
and nuclear translocation  
of the p65 subunit of nF-κB
Among MMP-9 expression regulators, the NF-κB sig-
naling pathway has been suggested.27 We therefore 
first assessed whether this signaling was activated upon 
PMA treatment and whether it was reflected in IκB 
degradation. PMA-mediated phosphorylation of IκB was 
assessed. HBMEC were treated for 45 min with 1 µM 
PMA following preincubation with either vehicle or with 
100 mM 2-DG. Preincubation with vehicle followed by 
PMA treatment rapidly led to IκB phosphorylation and to 
a concomitant decrease in IκB (Figure 3A, upper panels). 
When cells were preincubated with 2-DG (Figure 3A, 
lower panels), PMA-mediated IκB phosphorylation was 
significantly reduced (Figure 3B) as quantified by scan-
ning densitometry. Nuclear translocation of the p65 and 
p50 subunits of NF-κB is among the direct consequences 
of IκB phosphorylation. When nuclear extracts were 
isolated, we found that lower p65 nuclear translocation 
(Figure 4A) occurred when cells were treated both with 
PMA and 2-DG as compared to PMA alone (Figure 4B). 
This is in agreement with the reduced phosphorylation of 
IκB observed in Figure 3.
2-Deoxy-D-glucose potentiates  
PMA-induced cyclooxygenase-2  
and gRP78 expression
As PMA is also a well documented inducer of cyclooxy-
genase-2 (COX-2),28 we determined whether 2-DG also 
inhibited a possible NF-κB signaling pathway that leads to 
COX-2 induction. Cells were first treated with PMA or a 
combination of PMA/2-DG or PMA/Man (mannose served 
as an osmotic control). PMA induced COX-2 expression, 
which was exacerbated in PMA/2-DG-treated cells, which 
had increased GRP78 expression further (Figure 5A, left 
panel). These effects were not observed in PMA/Man-treated Journal of Inflammation Research 2011:4
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cells (Figure 5A, right panel). To investigate the dose-
dependent effect, cells were incubated with vehicle or PMA 
in the presence of various 2-DG concentrations for 24 h. No 
COX-2 expression was observed in the absence of PMA, 
while a slight basal increase in the ER stress marker GRP78 
was noticed with increasing 2-DG treatment (Figure 5B, left 
panel). As expected, COX-2 expression was significantly 
induced by PMA (Figure 5B, right panel), and this induc-
tion was dose-dependently potentiated by 2-DG (Figure 5C). 
This 2-DG-mediated potentiation is in contrast to the results 
seen with MMP-9 and with the reduced NF-κB signaling 
described above (Figure 3 and Figure 4). Interestingly, we 
also found that the 2-DG-mediated expression of the ER 
stress marker GRP78 was potentiated upon PMA treatment 
(Figure 5D). Altogether, our data suggest ATP depletion 
affects PMA-mediated signaling independent of NF-κB and 
results in both decreased MMP-9 levels and in increased 
COX-2 expression. The latter is possibly a consequence of 
ER stress induction.
Increased endoplasmic reticulum 
stress, rather than MMP-mediated 
ecM hydrolysis, correlates with 
cyclooxygenase-2 expression in hBMec
As a consequence of the results above, we suspected a 
  correlative relationship that would direct the molecular 
events observed following intracellular ATP depletion within 
HBMEC. Accordingly, we plotted GRP78 vs COX-2 as well 
as MMP-9 vs COX-2 and confirmed a positive correlation 
between ER stress and COX-2 expression (Figure 6A). As for 
MMP-9 and its possible involvement in the ECM degradation 
required for tubulogenesis to occur, we instead found an 
inverse correlation when plotted against COX-2 expression 
(Figure 6B). Collectively, this suggests that intracellular 
ATP needs are crucial for cell survival signaling through 
ER stress-mediated events that would lead to a proinflam-
matory phenotype.
2-Deoxy-D-glucose-induced autophagy  
is abrogated in PMa-treated hBMec
Given that 2-DG treatment of the cells did not result in 
any cytotoxic effect (Figure 1B), we tested the possible 
implication of autophagy, a crucial component of the cellular 
stress adaptation response that maintains cell homeostasis and 
that may act as a survival mechanism that can rescue cells 
from apoptotic/necrotic death. HBMEC were treated in the 
presence of 100 mM 2-DG in combination or not with PMA. 
The acidic autophagic vesicles were visualized by supravital 
staining with a pH-sensitive dye acridine orange and fluores-
cent microscopy used to for visualization (Figure 7A). We 
observed that 2-DG, but more importantly PMA, triggered 
autophagic vacuoles formation which effect was slightly 
increased in the presence of combined 2-DG/PMA treat-
ment. When flow cytometry was used to quantify the extent 
of autophagy, we found that 2-DG induced by 2.4-times 
autophagy (Figure 7B). PMA treatment alone triggered 
extensive autophagy, but when combined to 2-DG no increase 
(1.1-times over basal) in autophagy was observed.
Discussion
The adaptive mechanisms responsible for EC survival under 
pro-carcinogenic and low energy conditions remain poorly 
documented. Although increasing interest has been 
manifested towards cancer therapies that target cell 
metabolism, very few studies have specifically assessed the 
impact of targeting the EC metabolic compartment. In fact, 
EC are believed to be metabolically robust and to adapt to Journal of Inflammation Research 2011:4
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performed as described in the Methods section. B) hBMec were treated as in (a) with various doses of 2-Dg. lysates were isolated, electrophoresed via sDs-Page, and 
immunodetection of cOX-2, gRP78, and gaPDh was performed as described in the Methods section. C) scanning densitometry of cOX-2 expression was only performed 
in PMa-treated cells since no cOX-2 was detectable in vehicle-treated cells. D) scanning densitometry of gRP78 expression was performed in vehicle- and in PMa-treated 
cells.
Abbreviations: hBMec, mitovasuila endothelial cells; PMa, phorbol 12-myristate 13-acetate; 2-Dg-glucose; Page, pohyacrylanide electrophoresis; gaDPh, glyceraldetyde, 
3-phisiphate; man, mannose.
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Figure 6 Increased endoplasmic reticulum stress, rather than MMP-mediated ecM hydrolysis, correlates with cyclooxygenase-2 expression in hBMec. The effects of PMa 
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pro-carcinogenic paracrine stimulation and conditions such 
as encountered within the hypoxic tumor microenvironment.29,30 
In our study, we induced in vitro procarcinogenic stimulation 
of brain microvascular endothelium using PMA in 
combination with ATP-depleting culture conditions in order 
to assess EC angiogenic and inflammatory responses. 
While preformed endothelial structures remained unaffected 
by 2-DG-mediated ATP depletion, we show that minimal Journal of Inflammation Research 2011:4 submit your manuscript | www.dovepress.com
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supply of energy is required by HBMEC for tubulogenesis 
processes to occur and that the acquisition of a proinflam-
matory phenotype better correlates with induction of   
ER  stress  than  with  increased  ECM  degradation 
capacities. This is among the first demonstration linking 
molecular players such as GRP78 (ER stress) and COX-2 
(inflammation) expression to the adaptative survival mecha-
nisms of vascular EC’s response to procarcinogenic and 
ATP-  depleting conditions. More importantly, this also in   
part demonstrates the crucial requirement for ATP in the 
early time points of tubulogenesis processes, while   preformed 
vessels may adopt metabolic adaptative mechanisms enabling 
them to resist energy   depletion. Alternate strategies, aside 
from using energy depletion agents, must therefore be 
envisioned in order to target preformed tumor-associated 
vessels, while optimization of antiangiogenic therapies may 
be complemented with ATP-depleting strategies.
EC are the first cells to be exposed to decreases in 
PO2 within a hypoxic tumor-associated environment. 
Accordingly, tight regulation of ATP and GTP turnover 
exists, which enables EC to maintain their high-energy 
phosphates during hypoxia.31 In EC, ATP is also pre-
dominantly generated by glycolysis and O2 consumption 
is compar  atively low.29 Although accelerated glycolysis 
is one of the biochemical characteristics of cancer cells 
metabolism, one can safely extrapolate that this metabolic 
shift alteration, in part consequent to the hypoxic tumor 
microenvironment, must also occur within the tumor-
associated vascular endothelium. Accordingly, it was 
demonstrated that low energy demand and high glycolytic 
activity may explain why the coronary endothelium is 
less severely injured than cardiomyocytes in ischemic and 
anoxic hearts.29 Targeting glycolysis in the tumor-associated 
vascular compartment may become an attractive antiangio-
genic approach. As such, besides affecting cell death and 
stress signaling pathways, 2-DG was recently shown to 
activate autophagy via ER stress rather than ATP depletion 
in cancer cell lines.32 Autophagy is a crucial component of 
the cellular stress adaptation response that maintains mam-
malian homeostasis, a process believed to protect against 
neurodegenerative and inflammatory conditions, aging, and 
cancer. Similar to tumor cells defense mechanisms, one 
can therefore hypothesize that the ER stress consequent to 
2-DG treatment in tumor-associated EC may contribute to 
autophagy and promote cell survival (this study). While 
protective effects of autophagy were observed in the cancer 
cell compartment in both laser-induced cell death33 and in 
resveratrol-induced cytotoxicity in glioma cells,34 inhibition 
of autophagy was on the other hand found to potentiate 
antiangiogenic effects of sulforaphane in an EC model.35 
Our study provides evidence supporting the latter assump-
tion whereas 2-DG-mediated inhibition of autophagy was 
only observed in carcinogen-treated HBMEC (Figure 7B). 
Deployment of therapeutic strategies to block autophagy 
for cancer and/or antiangiogenic therapy may therefore be 
envisioned.
Our study documents the effects of limited intracellular 
ATP levels not only on the EC angiogenic properties but 
also on their capacity to express inflammatory markers. We 
showed that ATP depletion upon procarcinogenic stimula-
tion with PMA exacerbates COX-2 expression in HBMEC, 
an effect correlated to ER stress-mediated mechanism. It 
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Figure 7 2-Dg induced autophagy is abrogated in PMa-treated hBMec. autophagy 
was assessed as described in the Methods section in vehicle, 100 mM 2-Dg-, 1 µM PMA-, 
and 100 mM 2-Dg/1 µM PMa-treated hBMec. A) Representative microphotographs 
of  the  formation  of  acidic  vesicular  organelles  were  taken  upon  acridine  orange 
staining. B) The extent of autophagy was further confirmed by flow-cytometry of 
acridine orange stained cells and the percent of autophagy indicated for each condition. 
In between parenthesis, the extent of autophagy induction is indicated.
Abbreviations: hBMec, mitovasuila endothelial cells; PMa, phorbol 12-myristate 
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has been established that COX-2 is usually undetectable 
in normal tissues, but can be induced through several 
stimuli, including mitogens, growth factors, hormones, 
and   cytokines.36 In recent years, many molecular pathways 
have been proposed to explain how increased COX-2, and 
the resulting prostaglandin over-production, may contribute 
to carcinogenesis.37 COX-2 mediates this role through the 
specific production of PGE2 that acts to inhibit apoptosis, 
promote cell proliferation, stimulate angiogenesis, and 
decrease immunity.38 To date, only few reports document an 
association between COX-2 expression and survival in EC 
consequent to tissue injury. In fact, it is believed that sepsis, 
consequent to the release of the endotoxin lipopolysaccha-
ride (LPS) by Gram-negative bacteria, is regulated through 
induction of COX-2 expression. One can therefore envision 
a close parallel between proinflammatory molecular mecha-
nisms involved in endotoxin-induced brain tissue injury 
and inflammation associated to brain tumor development. 
Interestingly, LPS-induced COX-2 expression was recently 
reported in bEnd.3 mouse brain endothelial cells.39 This 
study actually provides strong support to our study as the 
contribution of NF-κB (p65) activation was reported to also 
regulate COX-2.39 Noteworthy, LPS-induced adenosine was 
demonstrated to promote angiogenesis by the upregulation 
of VEGF expression in macrophages.40 Whether such a 
conceptual model impacts on the link between proinflam-
matory COX-2 and increased tumor angiogenesis remains 
to be further investigated.
On the other hand, moderate activity of the ER stress 
response system exerts an antiapoptotic function and sup-
ports tumor cell survival and chemoresistance, whereas more 
severe aggravation may exceed the protective capacity of this 
system and turn on its proapoptotic module.38 In our study 
we demonstrate in vitro, through the combination of two 
pharmacologic approaches, that increased COX-2 expression 
only occurs within those EC which possess low intracellular 
ATP levels and which are cultured under procarcinogenic 
conditions. 2-DG-mediated ATP depletion combined with 
PMA-induced ER stress synergize and inhibit autophagy 
potential of PMA-treated cells, an effect which ultimately 
impacts on EC angiogenic properties (ie, low tubulogen-
esis and diminished MMP-9 secretion). Similar cytotoxic 
outcome was recently documented in human breast cancer 
cells where the HIV protease inhibitor nelfinavir (Vira-
cept; Agouron Pharmaceuticals Inc., La Jolla, CA) and the 
COX-2 inhibitor celecoxib (Celebrex; Pfizer, New York, NY) 
were combined and produced aggravated ER stress, which 
caused pronounced toxicity.38
In summary, the present study has demonstrated that 
minimal ATP is required for EC-mediated tubulogenesis to 
occur. Moreover, we provide evidence that combined ATP 
depletion and procarcinogenic signaling trigger exacerbated 
ER stress that leads to the acquisition of a proinflammatory 
phenotype as reflected by increased COX-2 induction. 
Altogether, the combined output of those mechanisms may 
further impact on the cell survival adaptative response and 
trigger antiangiogenic effects within the tumor-associated 
vascular endothelium.
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